Citigroup
IDXX icon

Citigroup’s Idexx Laboratories IDXX Stock Holding History

Citigroup’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,100
Closed -$432K – 7476
2020
Q3 		$432K Sell
1,100
-1,600
-59% -$592K ﹤0.01% 3978
2020
Q2 		$891K Hold
2,700
– – ﹤0.01% 3671
2020
Q1 		$654K Sell
2,700
-1,300
-33% -$339K ﹤0.01% 3615
2019
Q4 		$1.04M Sell
4,000
-3,700
-48% -$975K ﹤0.01% 3707
2019
Q3 		$2.09M Buy
7,700
+3,000
+64% +$835K ﹤0.01% 2819
2019
Q2 		$1.29M Buy
4,700
+1,700
+57% +$419K ﹤0.01% 3329
2019
Q1 		$671K Sell
3,000
-2,400
-44% -$495K ﹤0.01% 3855
2018
Q4 		$1M Buy
5,400
+3,100
+135% +$636K ﹤0.01% 3394
2018
Q3 		$574K Sell
2,300
-2,200
-49% -$534K ﹤0.01% 4114
2018
Q2 		$981K Buy
4,500
+2,500
+125% +$515K ﹤0.01% 3382
2018
Q1 		$383K Sell
2,000
-3,600
-64% -$664K ﹤0.01% 4265
2017
Q4 		$876K Buy
5,600
+3,200
+133% +$504K ﹤0.01% 3469
2017
Q3 		$373K Buy
2,400
+1,200
+100% +$190K ﹤0.01% 4394
2017
Q2 		$194K Sell
1,200
-500
-29% -$81.2K ﹤0.01% 4818
2017
Q1 		$263K Sell
1,700
-9,900
-85% -$1.36M ﹤0.01% 4434
2016
Q4 		$1.36M Buy
11,600
+11,100
+2,220% +$1.27M ﹤0.01% 3378
2016
Q3 		$56K Buy
+500
New +$52.7K ﹤0.01% 5595

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Citigroup's IDXX Position: Q2 2026 in Review

Citigroup increased its Idexx Laboratories (IDXX) stake by 38% in Q2 2026, buying an estimated $25.5M and bringing the position to 165,689 shares worth $87.2M. The position accounts for 0.03% of the portfolio, ranked #522.

Citigroup first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $92.3M in Q3 2025. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Citigroup held 165,689 shares of Idexx Laboratories worth $87.2M as of Q2 2026.
  • Citigroup bought 45,406 Idexx Laboratories shares in Q2 2026, an estimated $25.5M.
  • Idexx Laboratories made up 0.03% of Citigroup's portfolio in Q2 2026, its #522 holding.
  • Citigroup first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
  • Citigroup's Idexx Laboratories position peaked at $92.3M in Q3 2025.
  • 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.